Hypertension, cardiotrophin-1 and gp130: Three points to heart failure?

Journal of Hypertension

Volumn 25, Issue 10, 2007, Pages 2008-2010

  Pemberton, Chris J ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Canterbury Health Laboratories Endolab   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; GLYCOPROTEIN GP 130;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART PROTECTION; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 34748908885     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ef5632     Document Type: Note

References (20)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007-2018.
2. Katz AM. Pathophysiology of heart failure: identifying targets for pharmacotherapy. Med Clin North Am 2003; 87:303-316.
3. Molkentin JD, Dorn GW 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63:391-426.
4. Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 2007; 102:279-297.
5. Mann DL. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol 2003; 65:81-101.
6. Lopez B, Gonzalez A, Lasarte JJ, Sarobe P, Borras F, Diaz A, et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease? J Hypertens 2005; 23:625-632.
7. Pemberton CJ, Raudsepp SD, Yandle TG, Cameron VA, Richards AM. Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc Res 2005; 68:109-117.
8. Talwar S, Downie PF, Squire IB, Barnett DB, Davies JD, Ng LL. An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun 1999; 261:567-571.
9. Railson JE, Liao Z, Brar BK, Buddle JC, Pennica D, Stephanou A, et al. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes. Cytokine 2002; 17:243-253.
10. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, et al. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens 1999; 17:807-816.
11. Jougasaki M, Tachibana I, Luchner A, Leskinen H, Redfield MM, Burnett JC Jr. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. Circulation 2000; 101:14-17.
12. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, et al. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 2000; 32:1821-1830.
13. Robledo O, Fourcin M, Chevalier S, Guillet C, Auguste P, Pouplard-Barthelaix A, et al. Signaling of the cardiotrophin-1 receptor: evidence for a third receptor component. J Biol Chem 1997; 272:4855-4863.
14. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A 1996; 93:407-411.
15. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97:189-198.
16. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A 1995; 92:4862-4866.
17. Wollert KC, Chien KR. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med 1997; 75:492-501.
18. Zolk O, Ng LL, O'Brien RJ, Weyand M, Eschenhagen T. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation 2002; 106:1442-1446.
19. Gonzalez A, Ravassa S, Loperena I, Lopez B, Beuamont J, Querejeta R, et al. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens 2007; 25:2148-2157.
20. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, et al. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J Mol Cell Cardiol 2005; 38:185-192.